Also, a University of Queensland research has found ultrasound to be a safe approach to possibly treat symptoms of ...

The company will use the funds to accelerate commercialization of its brain-signal AI technology and expand its cognitive health applications.

The microbiome-based test carries US FDA Breakthrough Device status and is designed to rule out low-risk autism cases early ...

The Australian research, which aims to help people with motor neuron disease keep moving, is now testing AI to personalise ...

Tampa General Hospital Cancer Institute will integrate Reimagine's platform into its clinical pathways to reduce workforce ...

ADP participated as a new investor in Thatch's $40 million Series B funding round in April, which brought the company's total ...

The partnership comes three months after Thyme Care raised $97 million in funding, bringing its total raise to $275 million.

Ash will provide at-home biomarker testing to Noom users to provide insights into key health markers linked to chronic ...

The Order says it revokes attempts to paralyze the AI industry and establishes an AI Litigation Task Force to challenge State ...

The federal grants will support CranioSense’s development and validation of its non-invasive intracranial pressure monitoring ...

Med’s registry platform will work alongside WellSky’s network of home-based care organizations to let patients participate in ...

Executives pointed to faster-than-expected AI adoption in healthcare, shifting regulatory signals and growing demand for AI ...